Barbara Gayle Duncan's Net Worth

Barbara Gayle Duncan's net worth is estimated to be at least $5,606,209.37 as of 06/15/2024. CoreStreet's estimation of Barbara Gayle Duncan's net worth is based on their sale of stock and current holding of stock.

Barbara Gayle Duncan is Director at Jounce Therapeutics Inc. They have executed at least 17 trades of stock as per SEC Form 4 filings. Their most recent trade was for 10,000 units of JNCE stock on 09/15/2020. Their biggest sale was on 06/19/2013 when they sold 50,575 units of Intercept Pharmaceuticals Inc stock for $1,744,837.50. They typically trade 2 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $5,606,209.37
Most recent insider trade:
  • Sept. 15, 2020

Barbara Gayle Duncan's Insider Trading History

Jounce Therapeutics IncTitleAmountPriceTypeTotal Value
Sept. 15, 2020
Director10,000$10.00Sell$100,000.00
March 15, 2018
Director2,000$28.11Sell$56,220.00
Jan. 26, 2018
Director4,000$25.00Sell$100,000.00
Intercept Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Oct. 3, 2016
CAO147$163.20Sell$23,990.40
July 5, 2016
CAO146$145.11Sell$21,186.06
April 4, 2016
CFO144$130.76Sell$18,829.44
Jan. 4, 2016
CFO468$145.90Sell$68,281.20
Oct. 2, 2015
CFO1,054$163.17Sell$171,981.18
July 1, 2015
CFO1,000$242.10Sell$242,100.00
Jan. 5, 2015
CFO141$176.49Sell$24,885.09
Jan. 2, 2015
CFO1,000$156.40Sell$156,400.00
Oct. 1, 2014
CFO1,000$233.12Sell$233,120.00
April 14, 2014
CFO1,154$279.00Sell$321,966.00
July 8, 2013
CFO25,000$45.39Sell$1,134,750.00
June 19, 2013
CFO50,575$34.50Sell$1,744,837.50
May 28, 2013
CFO6,225$34.50Sell$214,762.50
May 20, 2013
CFO28,200$34.50Sell$972,900.00